Subscribe To Our Free Newsletter |
Strides Pharma soars 8% on USFDA nod for drug to treat heart diseases
Meanwhile, Strides said the board is scheduled to meet on September 25, to consider the combine CDMO interests of the group to become one of India's top specialty pharmaceuticals CDMOs